Encompass Design India approves ₹95.25 crore preferential equity issue
The premium consumer-brand company plans to issue 38.1 lakh equity shares at ₹250 each, including a ₹240 premium, subject to shareholder and regulatory approvals. The capital raise is positioned to strengthen its base for long-term growth.
What happened
Premium consumer-brand company Encompass Design India approved a preferential equity issue to raise ₹95.25 crore, strengthening its capital base for long-term
Key facts
- ₹95.25 crore
- 38,10,000 equity shares
- ₹250 per share
- ₹10 face value
- ₹240 premium per share
- Tata Chemicals Q1FY27 consolidated net profit: ₹60 crore
- Tata Chemicals net profit decline: 81%
Why this matters
The proposed ₹95.25 crore raise strengthens Encompass Design India’s capacity to fund strategic growth initiatives and pursue partnerships or acquisitions from a better-capitalized base.
What to watch
- Shareholder vote outcome and regulatory/stock-exchange approval status.
- Identity and quality of preferential allottees, especially any promoter, strategic or institutional participation.
- Post-issue equity share count, promoter holding changes and implied dilution for existing shareholders.
- Detailed use-of-proceeds disclosure and whether funds are directed toward growth assets versus routine working capital.
- Issue-price comparison with prevailing market price and any subsequent trading below ₹250.
- Quarterly revenue growth, EBITDA margin, inventory days, receivables and operating cash flow after allotment.
- Any follow-on capital raise, debt reduction, acquisition or expansion announcement.
- Seek shareholder approval and complete required exchange, corporate and regulatory filings.
- Disclose allottee identities, promoter participation, post-issue shareholding and the exact dilution percentage.
- Specify use-of-proceeds allocation across working capital, marketing, store/distribution expansion, product development, debt repayment or acquisitions.
- Complete allotment and receive funds within the applicable preferential-issue timeline.
- Translate fresh capital into measurable operating milestones such as revenue growth, wider distribution, improved inventory availability and margin performance.